Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Exercise and adequate nutritional control prevent weight loss during radiotherapy in head and neck cancer: A case report].

Semergen·2020
Same author

Effects of 3-butenyl isothiocyanate on phenotypically different prostate cancer cells.

International journal of oncology·2018
Same author

Co-morbidities and sleep apnoea severity. A study in a cohort of Portuguese patients.

Revista de neurologia·2016
Same author

Barriers in implementing research among registered nurses working in the care of the elderly: a multicenter study in Spain.

Applied nursing research : ANR·2015
Same author

Lactate minimum test during incremental running after a submaximal cycling exercise: a novel test with training applications for triathletes.

The Journal of sports medicine and physical fitness·2014
Same author

Plasma disposition kinetics of moxidectin after subcutaneous administration to pregnant sheep.

Journal of veterinary pharmacology and therapeutics·2014

Related Experiment Video

Updated: Apr 20, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

10.1K

Target driven preclinical screening for new antimitotic chemotherapy agents.

S Novío, M Freire-Garabal, M J Núñez1

  • 1Lennart Levi Stress and Neuroimmunology Laboratory, Department of Pharmacology, School of Medicine, C/ San Francisco, s/n, 15782 Santiago de Compostela, A Coruna, Spain. snl@usc.es.

Current Topics in Medicinal Chemistry
|December 2, 2014
PubMed
Summary

New cancer therapies target mitosis beyond microtubules. While promising, novel antimitotic drugs show limited efficacy compared to current agents, necessitating further research into new targets and combination strategies.

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.9K
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

7.9K

Related Experiment Videos

Last Updated: Apr 20, 2026

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes
09:44

High-throughput Screening for Chemical Modulators of Post-transcriptionally Regulated Genes

Published on: March 3, 2015

10.1K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.9K
Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics
12:28

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on: January 11, 2019

7.9K

Area of Science:

  • Oncology
  • Cell Biology
  • Pharmacology

Background:

  • Approved antimitotic therapies (microtubule-targeting agents) have efficacy limitations and side effects.
  • New strategies focus on novel mitosis targets to reduce patient side effects.

Purpose of the Study:

  • Review current and future strategies for novel antimitotic compound discovery.
  • Evaluate new targets and multifunctional inhibitors for cancer therapy.

Main Methods:

  • Literature review of antimitotic drug development.
  • Analysis of novel targets beyond microtubule dynamics.
  • Assessment of preclinical and clinical trial data for new agents.

Main Results:

  • New antimitotics target kinases, kinesins, and multiprotein complexes.
  • Preclinical data show promise, but clinical efficacy often matches current microtubule inhibitors.
  • Resistance and side effects remain challenges for both old and new agents.

Conclusions:

  • Developing novel antimitotic compounds requires identifying new protein targets.
  • Multifunctional inhibitors offer a promising strategy to overcome resistance and reduce side effects.
  • Further research is crucial for advancing cancer chemotherapy beyond microtubule-targeting agents.